Human Monoclonal Antibody Targeting the Heparan Sulfate Chains of Glypican-3 Inhibits HGF-Mediated Migration and Motility of Hepatocellular Carcinoma Cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Human Monoclonal Antibody Targeting the Heparan Sulfate Chains of Glypican-3 Inhibits HGF-Mediated Migration and Motility of Hepatocellular Carcinoma Cells
Authors
Keywords
-
Journal
PLoS One
Volume 10, Issue 9, Pages e0137664
Publisher
Public Library of Science (PLoS)
Online
2015-09-03
DOI
10.1371/journal.pone.0137664
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunotoxin targeting glypican-3 regresses liver cancer via dual inhibition of Wnt signalling and protein synthesis
- (2015) Wei Gao et al. Nature Communications
- Spherical Cancer Models in Tumor Biology
- (2015) Louis-Bastien Weiswald et al. NEOPLASIA
- Hepatocellular Carcinoma: Reasons for Phase III Failure and Novel Perspectives on Trial Design
- (2014) J. M. Llovet et al. CLINICAL CANCER RESEARCH
- Hepatocellular carcinoma: clinical frontiers and perspectives
- (2014) Jordi Bruix et al. GUT
- Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy
- (2014) Wei Gao et al. HEPATOLOGY
- Glypican-1 regulates myoblast response to HGF via Met in a lipid raft-dependent mechanism: effect on migration of skeletal muscle precursor cells
- (2014) Jaime Gutiérrez et al. Skeletal Muscle
- Met as a therapeutic target in HCC: Facts and hopes
- (2013) Silvia Giordano et al. JOURNAL OF HEPATOLOGY
- Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma
- (2013) M. Feng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeted Disruption of Heparan Sulfate Interaction with Hepatocyte and Vascular Endothelial Growth Factors Blocks Normal and Oncogenic Signaling
- (2012) Fabiola Cecchi et al. CANCER CELL
- Discovery of PG545: A Highly Potent and Simultaneous Inhibitor of Angiogenesis, Tumor Growth, and Metastasis
- (2012) Vito Ferro et al. JOURNAL OF MEDICINAL CHEMISTRY
- High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screening
- (2012) Yen Phung et al. mAbs
- Identification of Cell Surface Proteins as Potential Immunotherapy Targets in 12 Pediatric Cancers
- (2012) Rimas J. Orentas et al. Frontiers in Oncology
- Glypican-5 stimulates rhabdomyosarcoma cell proliferation by activating Hedgehog signaling
- (2011) Fuchuan Li et al. JOURNAL OF CELL BIOLOGY
- Heparan Sulfate Proteoglycans
- (2011) S. Sarrazin et al. Cold Spring Harbor Perspectives in Biology
- Association of glypican-3 expression with growth signaling molecules in hepatocellular carcinoma
- (2010) Noriyuki Akutsu WORLD JOURNAL OF GASTROENTEROLOGY
- Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma
- (2009) Hirofumi Shirakawa et al. CANCER SCIENCE
- Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
- (2009) Chun-Jen Liu et al. JOURNAL OF HEPATOLOGY
- PI-88: a novel inhibitor of angiogenesis
- (2008) Ragini Kudchadkar et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells
- (2008) Takuma Aikawa et al. JOURNAL OF CLINICAL INVESTIGATION
- Glypicans
- (2008) Jorge Filmus et al. GENOME BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now